Structural Biology and Molecular Modelling Market

1
Structural Biology and Molecular Modeling Market
To Reach USD 14.97 Billion By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
Structural Biology and Molecular Modeling
Market The rising presence of contract research
organizations, increasing healthcare IT spending,
and unprecedented evolution of the healthcare
infrastructure and standards, rise in the
prevalence of chronic diseases are key factors
contributing to high CAGR of structural biology
and molecular modeling during the forecast
period. Market Size USD 4 Billion in 2018,
Market Growth - CAGR of 17.9, Market Trends
Product launches and research for advanced
Structural biology and molecular modeling
3
Our Approach
Market Summary

• According to the current analysis of Reports and
  Data, the global structural biology and molecular
  modeling market was valued at USD 4.00 billion in
  2018 and is expected to reach USD 14.97 billion
  by the year 2026, at a CAGR of 17.9. The global
  structural biology and molecular modeling market
  is an essential part of the worldwide healthcare
  sector and has already made vital contributions
  in obtaining remedies to several diseases.
• Improving the quality of medicine and healthcare,
  in general, has been a key focus of governments
  across the world in recent years due to the
  rising volume of patient demographics and the
  growing geriatric population. This has driven
  consistent investment in medical research in
  recent years, making steady development of the
  structural biology and molecular modeling
  techniques market likely in the future
• Request for a sample of this research report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /2233

4
Our Approach
Market Summary

• Further key findings from the report suggest
• Researchers of the University of Natural
  Resources and Life Sciences in Austria proceed
  out molecular dynamics simulations to study the
  activity of humanized antibodies (Ab2/3H6), which
  is believed to neutralize HIV-1.
• Large drug attrition rate associated with
  late-phase clinical trials in drug development is
  a significant contributor of the elevated costs,
  which is further presumed to propel the demand
  for modeling techniques to reduce the probability
  of drug failure.
• Potency determination of a new drug molecule in
  the silicon screening of 3-D chemical structures
  expedite the lead discovery and optimization
  process, thereby allowing the greater focus to be
  laid on targets with high therapeutic potential.
• North America captured a dominant share in the
  overall structural biology molecular modeling
  techniques market with 35. Heightening their RD
  capabilities to ensure high medical standards is
  expected to propel the demand in this region.
• To identify the key trends in the industry, click
  on the link below https//www.reportsanddata.com/
  report-detail/structural-biology-and-molecular-mod
  eling-market

5
Our Approach
Market Summary

• The key players are AlDassault Systemes, Agile
  Molecule, Accellera Ltd., Bioinformatic LLC,
  Affymetrix, Agilent Technologies, Inc., Illumina,
  Bruker Daltonics Inc., Biomax Informatics AG,
  Chemical Computing Group, and CLC bio
• For the purpose of this report, Reports and Data
  has segmented the market on the basis of source,
  product, application, and region
• Product (Revenue, USD Million 20162026)
• SaaS standalone modeling
• Homology modeling
• Threading
• Molecular dynamics
• Ab Initio
• Hybrid
• Others
• Visualization analysis
• Databases
• Others

6
Our Approach

• Application (Revenue, USD Million 20162026)
• Drug development
• Drug discovery
• Others
• Regional Outlook (Revenue in USD Million
  20162026)
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of the Europe
• Order Now https//www.reportsanddata.com/checkout
  -form/2233

7
About Us
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com